| AKAA.K.A. Brands Holding Corp. |
US$ 600,2 mi |
-5,2% |
2025 |
| ATENA10 Networks, Inc. |
US$ 290,6 mi |
14,5% |
2025 |
| AZA2Z CUST2MATE Solutions Corp. |
US$ 7,9 mi |
-477,6% |
2025 |
| YCYAA Mission Acquisition Corp. II |
n/d |
n/d |
n/d |
| AAONAaon, Inc. |
US$ 1,4 bi |
7,5% |
2025 |
| AIRAar Corp |
US$ 3,3 bi |
5,7% |
2026 |
| ABCFFAbacus Mining & Exploration Corp |
n/d |
n/d |
n/d |
| ABBNYAbb Ltd |
US$ 32,2 bi |
11,6% |
2023 |
| ABTAbbott Laboratories |
US$ 44,3 bi |
14,7% |
2025 |
| ABEOAbeona Therapeutics Inc. |
US$ 5,8 mi |
1.223,1% |
2025 |
| ANFAbercrombie & Fitch Co |
US$ 5,3 bi |
9,6% |
2025 |
| MGFAberdeen Government Markets Income Fund |
n/d |
n/d |
n/d |
| IFNAberdeen India Fund, Inc. |
n/d |
n/d |
n/d |
| MINAberdeen Intermediate Income Fund |
n/d |
n/d |
n/d |
| MMTAberdeen Multi-Market Income Fund |
n/d |
n/d |
n/d |
| MFMAberdeen Municipal Income Fund |
n/d |
n/d |
n/d |
| ABMAbm Industries Inc |
US$ 8,7 bi |
1,9% |
2025 |
| FAXAbrdn Asia-Pacific Income Fund, Inc. |
n/d |
n/d |
n/d |
| IAFAbrdn Australia Equity Fund, Inc. |
n/d |
n/d |
n/d |
| AGIGAbundia Global Impact Group, Inc. |
US$ 410,6 mil |
-7.172,4% |
2025 |
| ABVCAbvc Biopharma, Inc. |
US$ 296 mil |
-2.671,8% |
2025 |
| ACIUAC Immune SA |
CHF 3,6 mi |
-1.971,6% |
2025 |
| ACTGAcacia Research Corp |
US$ 285,2 mi |
7,6% |
2025 |
| ACADAcadia Pharmaceuticals Inc |
US$ 1,1 bi |
36,5% |
2025 |
| AKRAcadia Realty Trust |
US$ 410,8 mi |
4,1% |
2025 |
| ACHAccendra Health Inc |
US$ 2,8 bi |
-39,8% |
2025 |
| ACCSACCESS Newswire Inc. |
US$ 22,6 mi |
19,0% |
2025 |
| ACCOACCO BRANDS Corp |
US$ 1,5 bi |
2,7% |
2025 |
| ARAYAccuray Inc |
US$ 401,9 mi |
-12,2% |
2026 |
| ACHVAchieve Life Sciences, Inc. |
n/d |
n/d |
2025 |
| ACIWAci Worldwide, Inc. |
US$ 1,8 bi |
12,9% |
2025 |
| ACMRACM Research, Inc. |
US$ 901,3 mi |
10,4% |
2025 |
| ACUAcme United Corp |
US$ 196,5 mi |
5,2% |
2025 |
| ACNBAcnb Corp |
US$ 191,8 mi |
19,3% |
2025 |
| ACFNAcorn Energy, Inc. |
US$ 11,5 mi |
21,9% |
2025 |
| ACGCACP Holdings Acquisition Corp. |
n/d |
n/d |
n/d |
| ACRACRES Commercial Realty Corp. |
US$ 79,9 mi |
35,0% |
2025 |
| ACBMAcro Biomedical CO., Ltd. |
US$ 0 |
n/d |
2025 |
| ASNSActelis Networks Inc |
US$ 3,7 mi |
-225,0% |
2025 |
| ACTUActuate Therapeutics, Inc. |
n/d |
n/d |
2025 |
| AYIAcuity Inc. (DE) |
US$ 4,3 bi |
9,1% |
2025 |
| ACVAACV Auctions Inc. |
US$ 759,6 mi |
-8,7% |
2025 |
| ADMGAdamant Dri Processing & Minerals Group |
n/d |
n/d |
2022 |
| ADAMAdamas Trust, Inc. |
n/d |
n/d |
2025 |
| ADXAdams Diversified Equity Fund, Inc. |
n/d |
n/d |
n/d |
| PEOAdams Natural Resources Fund, Inc. |
n/d |
n/d |
n/d |
| ADCTADC Therapeutics SA |
US$ 81,4 mi |
-175,3% |
2025 |
| ATXGAddentax Group Corp. |
US$ 5,4 mi |
-83,2% |
2026 |
| ADIGAdi Global Distribution Inc. |
n/d |
n/d |
n/d |
| ADILAdial Pharmaceuticals, Inc. |
n/d |
n/d |
2025 |